ACAD (STOCKS)
Acadia Pharmaceuticals Inc.
$28.200000
-1.250000 (-4.24%)
Prev close: $29.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Catherine Owen Adams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,625.23M
- Employees
- 654
- P/E (TTM)
- 13.26
- P/B (TTM)
- 3.88
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
14
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.18 | $0.06 | +0.1214 | +207.17% |
|
Mar 2026 (Q1)
|
$0.02 | $0.06 | -0.0433 | -68.40% |
|
Dec 2025 (Q4)
|
$1.60 | $0.14 | +1.4602 | +1,044.49% |
|
Sep 2025 (Q3)
|
$0.42 | $0.15 | +0.2690 | +178.15% |
Financial Statements
| Revenues | $1.14B |
| Benefits Costs and Expenses | $1.02B |
| Cost Of Revenue | $100.98M |
| Costs And Expenses | $1.05B |
| Gross Profit | $1.04B |
| Operating Expenses | $951.30M |
| Selling, General, and Administrative Expenses | $620.29M |
| Research and Development | $331.01M |
| Operating Income/Loss | $86.37M |
| Income/Loss From Continuing Operations After Tax | $380.48M |
| Income/Loss From Continuing Operations Before Tax | $121.37M |
| Income Tax Expense/Benefit | -$259.12M |
| Net Income/Loss | $380.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $380.48M |
| Net Income/Loss Available To Common Stockholders, Basic | $380.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.26 |
| Diluted Earnings Per Share | $2.23 |
| Basic Average Shares | 340,418,000 |
| Diluted Average Shares | 344,303,000 |
| Assets | $1.74B |
| Current Assets | $1.22B |
| Inventory | $108.67M |
| Other Current Assets | $1.12B |
| Noncurrent Assets | $518.36M |
| Fixed Assets | $17.11M |
| Other Non-current Assets | $501.25M |
| Liabilities | $436.29M |
| Current Liabilities | $361.44M |
| Accounts Payable | $44.57M |
| Wages | $35.35M |
| Other Current Liabilities | $281.52M |
| Noncurrent Liabilities | $74.86M |
| Equity | $1.31B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.31B |
| Liabilities And Equity | $1.74B |
| Net Cash Flow From Operating Activities | $160.32M |
| Net Cash Flow From Operating Activities, Continuing | $160.32M |
| Net Cash Flow From Investing Activities | -$77.47M |
| Net Cash Flow From Investing Activities, Continuing | -$77.47M |
| Net Cash Flow From Financing Activities | $46.81M |
| Net Cash Flow From Financing Activities, Continuing | $46.81M |
| Net Cash Flow | $129.66M |
| Net Cash Flow, Continuing | $129.66M |
| Comprehensive Income/Loss | $379.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $379.12M |
| Other Comprehensive Income/Loss | $70.42M |